Deals14 Mar 2026, 03:01 pm
Promoter Sudhir Sethi Acquires 0.06% Shares in Beryl Drugs Ltd
AI Summary
Sudhir Sethi, the main Promoter & Director of Beryl Drugs Ltd, has acquired 3040 shares of the company, which constitutes 0.06% of the total shares. This disclosure was made under Regulation 7(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Key Highlights
- Sudhir Sethi, a Promoter & Director of Beryl Drugs Ltd, has acquired 3040 shares of the company.
- The acquired shares constitute 0.06% of the total shares of the company.
- The acquisition was disclosed under Regulation 7(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
BERLDRGPharmaceuticals
BERYL DRUGS LTD.Price Impact